Edison Liu

2016 Elected Fellow, American Association for the Advancement of Science

2008 Associate (Foreign) Member European Molecular Biology Organization (EMBO)

Edison T. Liu, M.D., is the president and CEO of The Jackson Laboratory, and was the president of Human Genome Organization, HUGO from 2007-2013.

2007 Doctor of Medical Science honoris causa - Awarded by Queen's University Belfast

2007–present President, HUGO (Human Genome Organisation)

2007-2009 Chairman, Health Sciences Authority (HSA), Singapore

2007–present Keystone Symposia Scientific Advisory Board

Nov 2006–present Adjunct Professor of Johns Hopkins, Division of Molecular Medicine, Department of Medicine

2006 Board Member, National Healthcare Group (NHG), Singapore

2006 Deputy Chairman, Health Sciences Authority (HSA), Singapore

2006 Member, Editorial Advisory Board, Biomolecular Frontiers, National University of Singapore (NUS)

2005 National Healthcare Group (NHG), Singapore, Distinguished Contributor Award

2005-2008 Member, NUS High School Board of Governors

2005 Member, Search Committee for Deputy President (Research & Technology, NUS)

2004 University Autonomy, Governance, and Funding Steering Committee (MOE, Singapore, Member)

2003 Public Service Medal (National Day, 2003): for work in controlling SARS in Singapore (given by the Office of the President, Republic of Singapore)

2003 Bioethics Advisory Committee (Member), Singapore

2002-2003 National Health Group, Strategic Committee for Clinical Research (Singapore)

2002 Biomedical Sciences Executive Committee, A*STAR (Singapore)

2002-2006 General Motors Award, General Assembly (USA)

2002 National University of Singapore: Feasibility study team for the establishment of a multicampus university.

2002 Ministerial committee to re-evaluate Singapore’s secondary school system (Ministry of Education)

2001-2011 Executive Director, Genome Institute of Singapore

2001 President’s Life Sciences Committee (National University of Singapore)

2001 University Promotion and Tenuring Committee (National University of Singapore)

2001-2003 Genetically Modified Organisms Advisory Council (Singapore Government)

2000 Rosenthal Award, AACR: for the discovery that HER-2 status determines response to adjuvant chemotherapy with doxorubicin.

2000-2001 NCI-Ireland-Northern Ireland Cancer Consortium Governing Board (Member)

1999 Elected-Board of Directors, American Association for Cancer Research

1999-2000 Chair, General Motors Cancer Research Awards Committee: Mott Award

1999-2001 NIH Committee to establish NIH graduate program

1998-2001 NIH Building 10 Revitalization Committee

Between 1997 and 2001, he was the scientific director of the National Cancer Institute's Division of Clinical Sciences in Bethesda, Md., where he was in charge of the intramural clinical translational science programs. From 1987 to 1996, Dr. Liu was a faculty member at the University of North Carolina at Chapel Hill, where he was the director of the UNC Lineberger Comprehensive Cancer Center's Specialized Program of Research Excellence in Breast Cancer; the director of the Laboratory of Molecular Epidemiology at UNC's School of Public Health; chief of Medical Genetics; and the chair of the Correlative Science Committee of the national cooperative clinical trials group, CALGB.

1997-2001 NIH Clinical Research Revitalization Committee

1997-2001 Co-Chair, NIH Clinical Center Advisory Council

1997 Chairman, NIH Committee on Extramural/Intramural Investigations in the Clinical Center

1997 Molecular Epidemiology Coordinating Group, NCI

1996-2001 Director, Division of Clinical Sciences, National Cancer Institute, Bthesda, MD

1996 1996 Brinker International Award for Breast Cancer Research - Basic Research Award

1996 AACR - Clinical Cancer Research Committee, 1996

1996 NCI - Developmental Diagnostics Working Group, 1996

1996-1997 NIH Committee on the Recruitment and Career Development of Clinical Investigators

1996 Protocol Review and Monitoring Committee, NCI

1996 Faculty Search Committee, Division of Molecular Genetics

1995-1996 Chief, Division of Medical Genetics, School of Medicine

1995-1996 Professor, Departments of Medicine, Epidemiology, Biochemistry and Biophysics.

1995 American Society of Clinical Investigation (Membership)

1995-1996 National Action Plan on Breast Cancer - Biological Resources Working Group

1994 Faculty Search Committee: Cell Biology Program, Lineberger Cancer Center

1993-1995 Associate Professor, Departments of Medicine and Epidemiology and Biochemistry, University of North Carolina at Chapel Hill

1992-1996 Director, Specialized Program of Research Excellence in Breast Cancer (NIH designated)

1992-1994 American Society for Clinical Oncology: Program Committee

1992 Faculty Search Committee Program in Molecular Biology

1990-1994 Jefferson Pilot Award: University of North Carolina at Chapel Hill, Junior Faculty Award for Research Excellence

1990-1993 Komen Foundation Award for Breast Cancer Research (funding fellow salary)

1990-1992 Lineberger Cancer Center, SPA personnel compensation Committee

1990 Lineberger Cancer Center Planning Committee 14th Annual Symposium

1987-1993 Assistant Professor in Medicine and Oncology, School of Medicine University of North Carolina at Chapel Hill

1985-1988 Clinical Investigator Award, National Cancer Institute, K08-CA01036-02, Preceptor: Dr. J. Michael Bishop.

1983-1987 Postdoctoral Fellow - Dept. of Microbiology, University of California at San Francisco, CA (Dr. J. Michael Bishop)

1983-1985 Damon Runyan Cancer Fund Fellowship Preceptor: Dr. J. Michael Bishop (UCSF)

1982-1985 Hematology Fellowship, University of California San Francisco, Moffitt Hospital

1980-1982 Oncology Fellowship, Stanford University

1979-1980 Residency, Barnes Hospital - Washington University, St. Louis

1978-1979 Internship, Barnes Hospital - Washington University, St. Louis

1974 Ford Foundation Fellowship for Intensive Studies in Chinese, Stanford University

1972 National Science Foundation Fellowship in Chemistry 1972.

1969-1973 Stanford University, B.S. Chemistry, Psychology